MGRX

Handel nachbörslich: 1.49 -0.03 -1.97%

Mangoceuticals Inc (MGRX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Mangoceuticals Inc Stock (MGRX) Company Profile

Mangoceuticals Inc

Healthcare (1166)

(833) 626-4679

15110 DALLAS PKWY, SUITE 600, DALLAS

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MGRX's Discussions on Twitter

Vergleichen Sie MGRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MGRX Mangoceuticals Inc	1.52	20.26M	755.00K	-9.33M	-5.43M	-5.71
VEEV Veeva Systems Inc	282.61	46.43B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	59.18	12.01B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	59.31	10.79B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	101.28	9.27B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	38.67	7.03B	906.14M	-52.62M	89.62M	-0.3621

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc Stock (MGRX) Company Profile

Vergleichen Sie MGRX mit anderen Aktien

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

Mangoceuticals Inc Files For Mixed Shelf Of Up To $150 Million - MarketScreener

Mangoceuticals Strengthens Position with Equity Transactions - TipRanks

Mangoceuticals, Inc. (NASDAQ: MGRX) is a Stock Spotlight on 3/24 - The Globe and Mail

Mangoceuticals Amends Promissory Note with Indigo Capital - TipRanks

Mangoceuticals shares results from field studies on MGX-0024 - Yahoo Finance

Mangoceuticals (NASDAQ:MGRX) Shares Up 11.8% – Should You Buy? - Defense World

Mangoceuticals reports promising antiviral for poultry health By Investing.com - Investing.com Nigeria

Mangoceuticals reports promising antiviral for poultry health - Investing.com

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory - GlobeNewswire

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu - The Globe and Mail

Mangoceuticals, Inc. Terminates Agreements with Key Partners - TipRanks

MANGOCEUTICALS, INC. SEC 10-Q Report - TradingView

Erectile Dysfunction Treatment Market Generated - openPR.com

Tim Corkum on Mangoceuticals Inc. (NASDAQ: MGRX) Breaking into the High-Growth Oral Pouch Market with a Smokeless Tech Acquisition - InvestorNews

Mangoceuticals Settles Lawsuit with Stock Issuance - TipRanks

Geode Capital Management LLC Reduces Stock Holdings in Mangoceuticals, Inc. (NASDAQ:MGRX) - Defense World

Press Release Distribution & PR Platform - ACCESS Newswire

Mangoceuticals Inc’s latest rating changes from various analysts - knoxdaily.com

MGRX’s Market Ups and Downs: What’s Behind the 2023 Stock Performance? - investchronicle.com

Mangoceuticals Emerges as a Leader Amid Rapid Expansion of Oral Stimulant Pouch Market - InvestorNews

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - InvestorNews

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Gr - TradingView

Mangoceuticals acquires Smokeless Tech intellectual property - Investing.com

Mangoceuticals enters into agreement to acquire assets of Smokeless Technology - TipRanks

Mangoceuticals Acquires IP to Expand Product Line - TipRanks

Mangoceuticals acquires Smokeless Tech intellectual property By Investing.com - Investing.com South Africa

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile

Mangoceuticals to Acquire Smokeless Technology's Intellectual Property - marketscreener.com

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - The Manila Times

Mangoceuticals Announces Strategic Entry into High Growth - GlobeNewswire

MangoRx Targets $37B Pouch Industry: Acquires Smokeless Tech IP, Lands Former JUUL President - Stock Titan

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions - Yahoo Finance

MGRX’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Trading Day Review: Mangoceuticals Inc (MGRX) Loses Momentum, Closing at 2.04 - DWinneX

What to expect from Mangoceuticals Inc’s (MGRX) current quarter earnings? - uspostnews.com

Can Mangoceuticals Inc (NASDAQ: MGRX) Still Be Hot This Week? - Stocksregister

Stock market nears its worst April in 93 years - The Globe and Mail

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Corsicana Daily Sun

Mangoceuticals Disrupts $33B Health Market: 5 Revolutionary Products Including FDA-Approved Treatments - Stock Titan

Mangoceuticals Issues Bonus Shares to Leadership - MSN

Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World

MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa

MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada

Why FedEx (FDX) Stock Is Nosediving - The Globe and Mail

Mangoceuticals issues new shares from preferred stock conversion - Investing.com India

Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa

Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MGRX